0001574591-26-000002.txt : 20260106 0001574591-26-000002.hdr.sgml : 20260106 20260106164442 ACCESSION NUMBER: 0001574591-26-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260102 FILED AS OF DATE: 20260106 DATE AS OF CHANGE: 20260106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dier Mardi CENTRAL INDEX KEY: 0001574591 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39269 FILM NUMBER: 26512382 MAIL ADDRESS: STREET 1: C/O ACELYRIN, INC. STREET 2: 4149 LIBERTY CANYON RD. CITY: AGOURA HILLS STATE: CA ZIP: 91301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001796280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 471787157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 240 E. GRAND AVE. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 388-5600 MAIL ADDRESS: STREET 1: 240 E. GRAND AVE. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4-01062026_090138.xml X0508 4 2026-01-02 0001796280 Oric Pharmaceuticals, Inc. ORIC 0001574591 Dier Mardi C/O ORIC PHARMACEUTICALS, INC. 240 E. GRAND AVE., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 true false false false 0 Stock Option (right to buy) 8.17 2026-01-02 4 A 0 40000 0 A 2036-01-01 Common Stock 40000 40000 D 1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026. /s/ Christian Kuhlen, attorney-in-fact 2026-01-06